Literature DB >> 7310501

Hydrocephalus in cerebral cysticercosis. Pathogenic and therapeutic considerations.

R D Lobato, E Lamas, J M Portillo, R Roger, J Esparza, J J Rivas, M J Muñoz.   

Abstract

The cases of 11 patients with hydrocephalus secondary to cerebral cysticercosis are analyzed. Most of the patients had suffered from epilepsy before they developed hydrocephalic symptoms, and computerized tomography showed that infestation of the parenchyma coexisted with ventricular or cisternal colonization. In four cases, the parasitic vesicles compromised cerebrospinal fluid (CSF) flow in the ventricular system, resulting in internal hydrocephalus. Communicating hydrocephalus, caused by the presence of Cysticercus larvae in the basal cisterns (Cysticercus racemosus), or by the occurrence of a chronic basal meningitis, or both, developed in seven more patients. Changes in CSF pressure were related to the number and location of the cysts and to the leptomeningeal inflammatory reactions evoked by them. The majority of patients presented with a chronic and relatively normotensive hydrocephalus. All patients except one had identifiable ventricular or cisternal Cysticercus larvae; these patients were treated with open removal of the cysts, and did well. However, most of them had impairment of CSF flow through the basal cisterns and required permanent CSF shunting. Communicating hydrocephalus due to leptomeningeal scarring was also successfully managed with extracranial shunting. Epilepsy was controlled with anticonvulsant therapy. Although good lasting results may be obtained with aggressive treatment of neurocysticercosis, patients are liable to relapse because surgery is only palliative in most instances.

Entities:  

Mesh:

Year:  1981        PMID: 7310501     DOI: 10.3171/jns.1981.55.5.0786

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  25 in total

Review 1.  A comprehensive review of imaging findings in human cysticercosis.

Authors:  Bargavee Venkat; Neeti Aggarwal; Sushma Makhaik; Ramgopal Sood
Journal:  Jpn J Radiol       Date:  2016-02-23       Impact factor: 2.374

Review 2.  Diagnosis and treatment of neurocysticercosis.

Authors:  Theodore E Nash; Hector H Garcia
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

Review 3.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

4.  Neurocysticercosis presenting as focal hydrocephalus.

Authors:  Azharuddin Mohammed Malik; Md Dilawez Shamim; Mehtab Ahmad; Nasar Abdali
Journal:  BMJ Case Rep       Date:  2014-06-24

5.  Cysticercosis in the UK.

Authors:  E R Hitchcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-08       Impact factor: 10.154

6.  Enzyme-linked immunosorbent assay for the diagnosis of cerebral cysticercosis.

Authors:  I N Mohammad; D C Heiner; B L Miller; M A Goldberg; I G Kagan
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

Review 7.  Taenia solium cysticercosis.

Authors:  Héctor H García; Armando E Gonzalez; Carlton A W Evans; Robert H Gilman
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

8.  Lyme disease-related intracranial hypertension in children: clinical and imaging findings.

Authors:  Sriram Ramgopal; Rawad Obeid; Giulio Zuccoli; Catalina Cleves-Bayon; Andrew Nowalk
Journal:  J Neurol       Date:  2016-01-06       Impact factor: 4.849

9.  Brain cysticercosis treated with praziquantel. Report of six cases.

Authors:  J M Abad; J Fernańdez; A Bollar; M Gelabert; A Mostaza; A García-Allut
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

10.  Diagnosis and treatment of neurocysticercosis.

Authors:  Christina M Coyle; Herbert B Tanowitz
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.